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Background: Studies of the effects of electromagnetic fields (EMFs) on cartilaginous cells show a broad range of
outcomes. However EMFs are not yet clinically applied as standard treatment of osteoarthritis, as EMF effects are
showing varying outcomes in the literature. The aim of this study was to examine effects of EMFs (5 mT or 8 mT)
on osteoarthritic (OA) and non-OA chondrocytes in order to investigate whether EMF effects are related to
chondrocyte and EMF quality.
Methods: Pellets of human OA and non-OA chondrocytes were exposed to a sinusoidal 15 Hz EMF produced by a
solenoid. Control groups were cultivated without EMF under standard conditions for 7 days. Cultures were examined
by staining, immunohistochemistry and quantitative real-time PCR for RNA corresponding to cartilage specific proteins
(COL2A1, ACAN, SOX9).
Results: OA chondrocytes increased the expression of COL2A1 and ACAN under 5 mT EMF compared to control. In
contrast no changes in gene expression were observed in non-OA chondrocytes. OA and non-OA chondrocytes showed
no significant changes in gene expression under 8 mT EMF.
Conclusion: A 5 mT EMF increased the expression of cartilage specific genes in OA chondrocytes whereas in non-OA
chondrocytes no changes in gene expression were observed. An 8 mT EMF however showed no effect altogether. This
suggests that EMF effects are related to EMF but also to chondrocyte quality. Further studies about the clinical relevance
of this effect are necessary.
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Background
Osteoarthritis (OA) refers to a syndrome of joint pain
accompanied by functional limitation and reduced qual-
ity of life. OA has a high prevalence, which is expected
to increase due to the aging population and currently af-
fects over 40 million Europeans [1]. It is one of the lead-
ing causes of pain and disability in everyday life
worldwide. The severity of knee and hip OA disability
has been associated with a significant increase in all-
cause mortality and serious cardiovascular disease events
due to the avoidance of physical activities that exacer-
bate symptoms [2]. The socioeconomic impact is very
high due to the enormous and dramatically escalating
burden of this disease [3]. As there is no cure for OA, a
multimodal pharmacologic and non-pharmacologic ap-
proach followed by joint replacement is recommended
by most guidelines. However, non-invasive multimodal
approaches often only result in short term improvement
or fail altogether. Additional strategies are needed to
treat pain and improve joint function while minimizing
side effects. Biological effects of electromagnetic fields
(EMFs) in tissues were first described by Fukada and
Yasuda [4], who investigated the piezoelectric phenomenon
in bone. Electric and electromagnetic potentials were found
to not only affect osteogenesis but also have chondropro-
tective properties [5]. In animal studies EMFs reduced knee
OA lesions [6] and have the ability to antagonize the cata-
bolic activity of cytokines in cartilage explants [5, 7, 8].
Other studies indicate that EMFs may affect intracellular
calcium concentration triggering proteoglycan synthesis
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[9, 10]. EMF therapy has been shown to partially reduce
pain and improve mobility for the treatment of OA as
compared to placebo [2, 4, 11]. However, the question
whether EMFs should be used as standard therapy for
the treatment of OA remains open.
Experimental studies on EMFs are inconsistent with
regard to electromagnetic fields, effector cells or tissues
and effector responses. Two current reviews follow the
same search approach and analyzed the effect of EMF
for the treatment of OA as compared to placebo [2, 4].
The question remains whether EMF is generally a form
of therapy suitable for everybody, or whether there are
specific patients who might profit from a specific form
of EMF therapy. Previous studies have shown that EMFs
increase the chondrogenic potential of human mesen-
chymal stem cells (hMSCs) during chondrogenic differ-
entiation [12]. Most astonishing was the fact that
positive EMF effects occurred here only under subopti-
mal and not under optimal cellular conditions [12]. It is
not known whether the suboptimal chondrocytes seen in
OA respond differently to EMF than healthy chondro-
cytes. The aim of this study was to compare the effects
of EMFs on OA versus non-OA chondrocytes. To our
knowledge this is the first approach to specifically ad-
dress this question. We further investigated whether the
effect could be indeed by any EMF or whether a specific
EMF is necessary. We hypothesized that specific EMFs
would show more effects on degenerated osteoarthritic
than on non-osteoarthritic chondrocytes.
Methods
Cell culture
Human OA articular cartilage was obtained from adult
patients (patient 1-7) during total knee replacement
(n = 7) (1 male, 6 female; mean age 67; range 58 - 85).
Non-OA articular cartilage was obtained from young pa-
tients (patient 8-13) during triple arthrodesis performed
as salvage procedure for refactory clubfoot (n = 3) or from
human knee condyles of deceased patients after trauma
devoid of involvement of the knee harvested within 12 h of
death (n = 3) (together 5 male, 1 female; mean age 15;
range 13 - 20) (Fig. 1). The study was approved by the
Ludwig-Maximilians-University medical center ethics
committee. Chondrocytes were isolated by enzymatic
treatment using pronase (Roche Diagnostics, Mannheim,
Germany) and collagenase (Sigma-Aldrich, St. Louis, MO)
and cultured at 37 °C in a humidified atmosphere in Dul-
becco’s modified Eagle’s medium (DMEM)/Hams F-12
(1:1; Biochrom, Berlin, Germany) containing 10% fetal calf
serum (PAA, Pasching, Austria), 1% MEM–amino acids
(Biochrom, Berlin, Germany), 25 μg/ml ascorbic acid
(Sigma-Aldrich, St. Louis, MO), 50 IU/ml penicillin–
streptomycin and 0.25 μg/ml Amphotericin B (Biochrom,
Berlin, Germany). The medium was changed every second
day. At 100% confluence, cells were passaged using 0.05%
Trypsin containing 0.02% EDTA (Biochrom, Berlin,
Germany) and were expanded in monolayer triple flasks
(Nunc, Rosklide, Denmark). Experiments were performed
with chondrocytes at passage 2. At day zero, 4 × 105
chondrocytes were lysed in 1 ml TRIzol Reagent (Life
Technologies, Carlsbad, CA) and kept at −80 °C for
further RNA-analysis. To form pellet cultures (n = 10 for
each patient), 4 × 105 cells were centrifuged at 150 g for
5 min in a 15 ml polypropylene tube (TPP, Trasadingen,
Switzerland). All pellet cultures were cultured for 48 h
under the same conditions as mentioned above to allow
pellet formation. Experiments were started by transferring
pellets into 1.5 ml reaction tubes (Eppendorf, Hamburg,
Fig. 1 Chart of the experiment with 7 OA patients and 6 nonOA patients. During the experiment 5 pellet cultures per patient were exposed to an
EMF (5 mT or 8 mT). As control group 5 pellet cultures from the same patient were cultivated in a second incubator without a solenoid for 7 days
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Germany), containing 1 ml of medium and sealed by
breathe easy sealing membranes (Sigma-Aldrich,
Steinheim, Germany). During the experiment 5 pellet
cultures per patient (3 pellets for RNA-analyses and 2
pellets for histology and immunohistochemistry (IHC))
were exposed to EMF (5 mT or 8 mT) respectively
within a solenoid. The respective control pellet cultures
(n = 5) from the same patient were cultivated in a sec-
ond incubator without a solenoid for 7 days, established
as control [12] (Fig. 1). All experiments were performed
for 7 days, with media being changed every second day.
Low frequency sinusoidal EMF
EMFs were generated with a solenoid (FA-P6-K, Neue
Magnetodyn, Munich, Germany) combined with a fre-
quency generator (M80, Neue Magnetodyn, Munich,
Germany) as described by Mayer-Wagner et al. [12]. For
experiments, pellets were cultured in 1.5 ml Eppendorf-
Safe-Lock tube (Eppendorf, Hamburg, Germany) fixed in
a tube-rack inside the coil. To allow gas-exchange tubes
were closed with a permeable sealing membrane (Sigma-
Aldrich, Steinheim, Germany). The EMF waveform was
measured with a teslameter (Bell 640, F.W. Bell,
Orlando, FL) inside the coil at the position of the pellet
cultures.
In this configuration, the magnetic field is in parallel
to the long axis of the base of the tube-rack. The electric
field induced by the magnetic field in the plane of the
pellets can be calculated with good approximation by
the following equation: Eymax = 2hπfBxπf [13], where B
is the peak value of the magnetic flux density, fis its fre-
quency and h is the height of the pellets. With the given
values the maximum induced electric field is below
2 mV/m.
The particular waveform, amplitude and sinusoidal
frequency of 15 Hz have been established previously in
vivo [14, 15] and in vitro [12, 16, 17]. The homogeneity
of the magnetic field within the solenoid was assured by
measuring the spatial distribution of the magnetic flux
density with a teslameter. The geomagnetic field in the in-
cubator was determined to be 45 μT parallel to the rota-
tion axis of the solenoid. The field (either 5 mT or 8 mT)
was applied every 8 h for 45 min during the course of the
7 day experiment. The waveform was a pure sinusoidal
wave with a total harmonic distortion <1%. The 8 mT field
was applied in order to use an unspecific field, which has
so far not been shown in the literature to induce effects
but is still close to the 5 mT field described to produce an
effect.
Histology
Pellet cultures (2 with EMF treatment and 2 without
treatment for each patient) were washed in phosphate
buffered saline (PBS) pH 7.4, incubated in 5% sucrose
in PBS (21 °C, 15 min), dry embedded in Tissue-Tek
(Sakura, Zoeterwoude, Netherlands) and frozen at
−20 °C. Serial cryosections (8 μm) were prepared by
mounting pellet cultures on SuperFrost glass slides
(Menzel-Gläser, Braunschweig, Germany). Cryosec-
tions were fixed in acetone (AppliChem, Darmstadt,
Germany) and dried at room temperature (RT). Serial
sections were stained in triplicate with 0.75%
safranin-O (Fluka, Buchs, Switzerland) and 0.02% fast
green (Chroma, Münster, Germany).
Immunohistochemistry
Pellet sections were fixed in acetone (AppliChem,
Darmstadt, Germany) (10 min, RT) and washed in
washing buffer (PBS with 0.2% 5 Brij L23 Solution
(Sigma-Aldrich, Steinheim, Germany)). After blocking
endogenous tissue peroxidase activity with 0.3% H2O2
(Merck, Darmstadt, Germany) in aqua dest (4 min, RT)
pellet sections were treated with 0.25 U/ml chon-
droitinase AC from Flavobacterium Heparium (Sigma-
Aldrich, Steinheim, Germany) in PBS (30 min, 37 °C)
followed by washing in washing buffer. Afterwards
pellet sections were incubated with monoclonal mouse
antibodies (mABs) against collagen type I (Sigma-Aldrich,
Saint Louis, MO) diluted in 1:2000 in mAB-dilution-
soluion (DCS, Hamburg, Germany) or collagen type II
(DSHB, University of Iowa, IA) 1:6 in mAB-dilution-
solution (30 min, RT). For negative controls the mABs
were omitted. Pellet sections were washed in washing
buffer and then incubated with a biotinylated horse-anti-
mouse IgG (Vector Laboratories, Burlingame, CA) diluted
1:200 in mAB-dilution-solution (30 min, RT). Af-
terwards pellet sections were incubated with avidin-
biotin-peroxidase-complex (ABC) (Vector Laboratories,
Burlingame, CA). After repeated washing, the bound
mABs were visualized with 3.3 diamino benzidine tetrahy-
drochlorhide (DAB) (Vector Laboratories, Burlingame,
CA) for approximately 4 min without light. The reaction
was stopped with aqua dest. And the sections were coun-
terstained with haematoxylin (AppliChem, Maryland, CA)
and embedded in Eukitt (O-Kindler, Freiburg, Germany).
Representative images were obtained using a PreciPoint
M8 microscope (PreciPoint, Freising, Germany) (Fig. 2).
Visual histological grading system
The morphology of pellet cultures was graded according
to a visual histological grading system for generated neo-
cartilage [18]. Two independent and blinded observers
evaluated each pellet in 3 categories described below
and assigned scores ranging from 0 to 3. Categories were
added with equal weight to give a total score (Table 1).
Category A: Intensity of safranin-O staining. Each
sample was observed with a 10× objective.
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Category B: Distance between cells and amount of
matrix produced by chondrocytes were assessed with a
20× objective.
Category C: Cell morphology was examined using a
40× objective. A rounded morphology was expected for
chondrocytes and the presence of pyknotic or fibroblast
morphology was scored as poor cell quality.
RNA isolation
Cell pellets were disrupted under frozen conditions with
3000 rpm for 1 min, using a Micro-Dismembrator S
(Sartorius, Göttingen, Germany). Total RNA was iso-
lated directly from freeze-milled preparations, using
1 ml QIAzol Lysis Reagent (Qiagen, Hilden, Germany).
Fig. 2 Histology and Immunohistochemistry (IHC) staining of one OA-patient and one non-OApatient pellet cultures after 5 mT EMF exposition
(b, f, j, n, d, h, l, p) or without EMF exposition (a, e, i, m, c, g, k, o). Safranin-O staining (a, b, c, d) and alcian blue staining (e, f, g, h) was positive for
all pellet cultures. IHC for collagen type II was much more obvious for OA pellet culture after EMF exposition (j) and non-OA pellet cultures
with and without EMF exposition (k, l). IHC for collagen type I of OA pellet cultures (m, n) showed a weaker staining than non-OA pellet
cultures (o, p)
Table 1 Visual histological grading system
A B C total
OA
EMF 0 mT 1 1 1 3
EMF 5 mT 2 2 1 5
EMF 8 mT 1 1 1 3
Non-OA
EMF 0 mT 2 2 3 7
EMF 5 mT 2 2 3 7
EMF 8 mT 2 2 3 7
Three categories were evaluated: A intensity of safranin-O staining, B distance
between cells/amount of matrix that was accumulated and C cell
morphologies represented
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After addition of 0.2 ml chloroform (Sigma-Aldrich,
Steinheim, Germany), samples were shaken and incu-
bated at RT for 10 min. For phase separation, samples
were centrifuged at 15000 g for 20 min at 4 °C and the
aqueous phase was transferred to a fresh tube.
Total RNA precipitation was performed by mixing
0.5 ml Isopropanol (Sigma-Aldrich, Steinheim, Germany)
with the aqueous phase. After incubation at RT for 10 min
samples were centrifuged at 15000 g over night at 4 °C.
RNA pellets were washed twice with 1 ml 75% Ethanol
(Merck, Darmstadt, Germany) and centrifuged at 15000 g
for 20 min at RT. After drying pellets, total RNA was dis-
solved in 32 μl RNAse free water (Gibco, Darmstadt,
Germany). Concentration and purity was determined by
Nanodrop (ND-1000, Thermo Fisher, Waltham, MA).
Quantitative real-time polymerase chain reaction
(qRT-PCR)
For cDNA synthesis, 0.5 μg total RNA from each pellet
culture (3 with EMF treatment and 3 without treatment
for each patient) was reverse-transcribed using the
QuantiTect Reverse Transcription Kit (Quiagen, Hilden,
Germany). QRT-PCR was performed using a LightCycler
96 System (Roche Diagnostics, Mannheim, Germany).
Each reaction contained 5 μL of FastStart Essential DNA
Green Master Mix (Roche Diagnostics, Mannheim,
Germany), 2.5 μl of 1:3 diluted cDNA and 0.3 μl
(300 nM), for test genes or 0.5 μl (500 nM), for reference
gens of primer in a 10 μl final volume.
The following primers were used: Glycerinaldehyd-3-
phosphat-dehydrogenase (GAPDH) [19], collagen type II
α1 chain (COL2A1) [20], collagen type 1 α1 chain
(COL1A1) [21], cartilage-specific proteoglycan core pro-
tein (ACAN) [20] and SRY (sex determining region Y)-
box 9 (SOX9) [20] (Table 2).
Thermal cycling parameters included a denaturation
step for 10 min,40 cycles of 95 °C for 10 s, 60 °C /65 °C
for 10 s and 72 °C for 15 s. Reactions for each pellet
were performed in triplicate and the mean of relative
quantification values was calculated by using the delta-
delta Ct method [22] with GAPDH as the reference
gene. Box-plots (Fig. 3) of cartilage specific genes and
COL1A1 were established by normalizing qRT-PCR data
of pellets with 5 and 8 mT EMF treatment to the mean
of control pellets without EMF treatment.
Statistical analysis
All RNA variables were described graphically by box-
and-whisker plots and numerically using appropriate
measures of location and dispersion. Due to the posi-
tive skew of their distributions of our outcome vari-
ables, we used the decadic logarithms instead of the
original values as dependent variables in our models.
The appropriateness of the log transformation was
checked graphically using the residual plots for the
resulting models. The effects of diagnosis, electromag-
netic field strength, and their interaction with the
log-transformed outcome variables were explored by
means of mixed effects model with a random inter-
cept per patient using the MIXED procedure of the
Statistical Analysis System SAS, version 9.4 for Win-
dows (SAS Institute, Cary, NC, USA). P < 0.05 were
regarded as statistically significant.
Results
Histology and immunohistochemistry
Positive staining for safranin-O and alcian blue were
found in all pellet cultures. All pellet cultures showed
signs of collagen type II and type I with differences
in density. Representative images of pellet cultures are
shown in Fig. 2 with pellet sections from one OA pa-
tient cultured without EMF (Fig. 2a, e, i, m) and one
cultured with 5 mT EMF (Fig. 2b, f, j, n). Figure 2
also shows pellet sections from one non-OA patient
cultured without EMF (Fig. 2c, g, k, o) and one with
EMF 5 mT (Fig. 2d, h, l, p).
Comparing pellet cultures of non-OA to OA chondro-
cytes, non-OA cultures showed a more homogenous and
compact structure than pellets from OA chondrocytes.
A stronger staining for collagen type I was observed in
OA cultures (Fig. 2m, n). OA cultures treated with spe-
cific 5 mT EMF showed a similar staining for collagen
type II to non-OA cultures (Fig. 2j, k, l) whereas un-
treated OA pellets showed less staining for collagen type
II (Fig. 2i).
OA pellets treated with 8 mT showed no differences in
staining compared to the control OA group without
EMF (data not shown).
No differences in staining intensity for collagen type II
and collagen type I were found for pellet cultures of
non-OA chondrocytes which had been treated with
Table 2 Gene sequences of primer pairs and annealing
temperatures
Gene Sequence Annealing
temperature
GAPDH forward TGC ACC ACC AAC TGC TTA GC 60 °C
GAPDH reverse GGC ATG GAC TGT GGT CAT GAG 60 °C
COL2A1 forward GTT ATC GAG TAC CGG TCA CAG AAG 65 °C
COL2A1 reverse AGT ACT TGG GTC CTT TGG GTT TG 65 °C
ACAN forward CAG CAC CAG CAT CCC AGA 65 °C
ACAN reverse CAG CAG TTG ATT CTG ATT CAC G 65 °C
COL1A1 forward TGA CCT CAA GAT GTG CCA CT 65 °C
COL1A1 reverse ACC AGA CAT GCC TCT TGT CC 65 °C
SOX9 forward AGA CCT TTG GGC TGC CTT AT 60 °C
SOX9 reverse TAG CCT CCC TCA CTC CAA GA 60 °C
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EMF (5 mT/8 mT) versus the control non-OA group (5
mT data in Fig. 2; 8 mT data not shown).
Visual histological grading
Table 1 shows results of the visual histological grading
system. Pellets from OA patients with 5 mT EMF treat-
ments had a higher score in category A and B than in
the OA control group without EMF treatment. The pel-
lets from OA patients treated with 5 mT EMF did not
reach the scores from pellets of non-OA patients. OA
pellets treated with 8 mT showed the same score as the
untreated controls. Pellets from non-OA patients showed
no difference in all three categories (0 mT/5 mT/8 mT)
and presented the best cartilage-like cell morphology with
strong staining for collagen type II, formation possessed
the rounded morphology typical of chondrogenic cells
and are surrounded by an extracellular matrix (Table 1).
Quantitative real-time PCR
All pellet cultures from OA patients and non-OA pa-
tients expressed the cartilage specific markers COL2A1,
ACAN and SOX9 mRNA and the unspecific COL1A1
mRNA (Fig. 3a-d).
OA cultures from the 5 mT EMF treatment group pre-
sented with significantly higher expression (p < 0.001) of
COL2A1 and ACAN (p < 0.01) than the OA control
group with 0 mT EMF treatment (Fig. 3a, c). In contrast,
no changes in gene expression were observed in pellets
from non-OA patients.
OA cultures treated with 8 mT EMF showed also no
significant differences in gene expression compared to OA
control cultures with 0 mT EMF treatments (Fig. 3a-d).
No significant changes in gene expression were ob-
served for pellets from non-OA patients treated with or
without 8 mT EMF (Fig. 3a-d).
Discussion
Effects of 5 mTand 8 mT EMF on OA and non-OA chon-
drocytes were examined in a 3D culture system. The 5
mT EMF increased COL2A1 and ACAN gene expression
of OA chondrocytes. The 8 mT EMF did not show any ef-
fects on OA and non-OA chondrocytes gene expression.
The effects of EMFs on chondrocytes are inconsistent in
the literature [4, 23]. A specifically beneficial EMF is diffi-
cult to characterize as in the literature electromagnetic
fields with a broad range of intensity have been used in
similar settings. EMFs in the range from 0.5 up to 5 mT
seem to generate positive results on cartilage [11]. Within
this study a 5 mT EMF, which had previously been shown
to exert beneficial effects on the chondrogenic differenti-
ation of hMSCs [12], was examined versus an EMF of 8
mT. No effects of the 8 mT EMF on gene expression was
observed in OA nor in non-OA chondrocytes. It can
therefore be postulated that although there is a field
spectrum for beneficial effects of EMF on cartilaginous
Fig. 3 Alteration of normalized gene expression of COL2A1 (a), COL1A1 (b), ACAN (c) and SOX9 (d) to GADPH expressed by pellets of OA (n = 12 with
5 mT and n = 9 with 8 mT) and non-OA patients (n = 9 with 5 mT and 8 mT) after 7 days in a 5 mT or 8 mT EMF normalized to the respective control
group without (0 mT) EMF exposition
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cells, it is possible to reduce EMF effects by slight adjust-
ments to electromagnetic field.
As EMF effects depend very much on multiple param-
eters including frequency, magnetic field peak amplitude
as well as exposure length [24] we were interested
whether EMF effects also vary with on cell quality. To
our knowledge, studies comparing EMF effects on hu-
man OA to non-OA cartilage are lacking. In previous
published studies EMFs were applied to OA cartilage
explants, where they were shown to increase proteogly-
can synthesis after 7 days [7]. EMF effects were also ex-
amined in bovine articular cartilage explants, where an
EMF (2.3 mT, 60 Hz), increased proteoglycan synthesis
both under basal conditions and in the presence of
interleukin-1 [24]. Positive effects of 1, 2 and 3 mT 60 Hz
EMFs on the expression of cartilage specific genes and
glycosaminoglycan synthesis were also observed in non-
OA bovine chondrocytes [8]. When particular parameters
were used, EMFs were even able to prevent degenerative
changes in cartilage explants with a potency almost reach-
ing low-intensity pulsed ultrasound research [25].
During this study EMF effects on human OA and
non-OA chondrocytes were cleary divergent. The appli-
cation of 5 mT EMF resulted in an upregulation of
COL2A1 and ACAN gene expression in OA chondro-
cytes. In contrast to OA chondrocytes, non-OA chon-
drocytes did not seem to significantly profit from EMF.
Previoussimilar results were shown in a study of hMSCs
where EMF effects were only observed under suboptimal
cell culture conditions and EMF effects were dependent
on the cellular quality of the hMSCs [12]. Why EMF
stimulation is mainly effective in degenerated or subopti-
mal chondrogenic cells remains to be answered. Variable
reasons are possible to explain the stronger influence of
EMF on degenerated chondrocytes.
Regarding the pathogenesis of OA adenosine receptors
(ARs), A2A and A3 play an important role in the anti-
inflammatory pathway by decreasing expression of nuclear
factor κB (NF-κB) a transcriptional factor of inflammatory
cytokines such as interleukin-1 beta (IL-1ß), interleukin-6
(IL-6) and tumornecrosis factor alpha (TNF-α) [26]. EMFs
have been described to increase anti-inflammatory effects
by inducing up-regulation of A2A and A3 ARs [27, 28].
An other mechanism for a re-improvement of chondro-
genic potential through EMF may be increased growth
factor synthesis [29]. EMFs act on transforming growth
factor beta 1 (TGF-β1) -growth factor release and may
thereby restore the chondrogenic potential of degenerated
or suboptimal chondrogenic cells. In addition, EMFs may
have anti-apoptotic effects by decreasing the expression of
proteins involved in the pro-apoptotic pathway and simul-
taneously increasing expression of anti-apoptotic proteins
[30]. EMF treatment seems to improve suboptimal or de-
generate cellular conditions for chondrocytes [31, 32]. In
the absence of chondrocyte stress EMFs may be ineffective
which may in part explain the lack of EMF effect in some
studies. It also needs to be evaluated whether degener-
ation of tissue or the age of the donor are responsible for
the EMF effects. For general statements about degener-
ation and EMF effects, further studies are necessary to
clearly define this mechanism.
Conclusions
The application of 5 mT EMFs has a positive effect on
degenerated OA chondrocytes by increasing expression
of COL2A1 and ACAN. The effect of 5 mT EMFs on
non-OA chondrocytes is markedly less pronounced. 8
mT EMF did not exert an effect on OA or on non-OA
chondrocytes. Further studies are necessary to evaluate
EMF effects in different settings, which may be a valu-
able tool in treating OA patients.
Abbreviations
ABC: Avidin-biotin-peroxidase-complex; ACAN: Cartilage-specific
proteoglycan core protein; ARs: Adenosine receptors; COL1A1: Collagen type
1 alpha1 chain; COL2A1: Collagen type II alpha1 chain; DAB: 3.3 Diamino
benzidine tetrahydrochlorhide; DMEM: Dulbecco’s modified eagle’s medium;
EMFs: Electromagnetic fields; GAPDH: Glycerinaldehyd-3-phosphat-
dehydrogenase; hMSCs: Human mesenchymal stem cells;
IHC: Immunohistochemistry; IL–1β: Interleukin-1 beta; IL-6: Interleukin-6;
mABs: Monoclonal mouse antibodies; NF- κB: Nuclear factor κB;
OA: Osteoarthritis; PBS: Phosphate buffered saline; qRT-PCR: Quantitative real-
time polymerase chain reaction; RT: Room temperature; SOX9: SRY (sex
determining region Y)-box 9; TGF-β1: Transforming growth factor beta 1;
TNF-α: Tumornecrosis factor alpha
Acknowledgements
We thank Heribert Stephan (Neue Magnetodyn GmbH) for his sophisticated
technical support and methodical advice. We also thank Alexander Crispin
(IBE Munich) for his statistical support.
This work was presented by Julia Isabelle Redeker in partial fulfillment of the
requirements for a MD degree, Ludwig-Maximilians-University Medical
School, Munich, Germany.
Funding
This work was supported by Bayern Innovativ.
Availability of data and materials
All data generated or analysed during this study are included in this published
article.
Authors’ contributions
JR, BS, AB, CB, VJ and SM-W designed the experiments; JR, BS, CB and AB
performed the experiments; JR, BS and SM-W analysed data; JR, BS, AB, CB,
VJ and SM-W wrote the paper. All authors have read and approved the final
submitted manuscript.
Ethics approval and consent to participate
The study was approved by the Ludwig-Maximilians-University medical
center ethics committee.
Informed consent was obtained if necessary.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Redeker et al. BMC Complementary and Alternative Medicine  (2017) 17:402 Page 7 of 8
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Department of Orthopaedic Surgery, Physical Medicine and Rehabilitation,
Ludwig-Maximilians-University, Munich, Germany. 2Institute for Legal
Medicine, Ludwig-Maximilians-University, Munich, Germany. 3Institute of
Forensic Medicine, Rostock University Medical Center, Rostock, Germany.
Received: 10 November 2016 Accepted: 4 July 2017
References
1. Conaghan PG, Kloppenburg M, Schett G, Bijlsma JWJ, Comm EOAH.
Osteoarthritis research priorities: a report from a EULAR ad hoc expert
committee. Ann Rheum Dis. 2014;73:1442–5.
2. Li S, Yu B, Zhou D, He C, Zhuo Q, Hulme JM. Electromagnetic fields for
treating osteoarthritis. Cochrane Database Syst Rev. 2013:CD003523.
3. Hunter DJ, Schofield D, Callander E. The individual and socioeconomic
impact of osteoarthritis. Nat Rev Rheumatol. 2014;10:437–41.
4. Negm A, Lorbergs A, Macintyre NJ. Efficacy of low frequency pulsed subsensory
threshold electrical stimulation vs placebo on pain and physical function in
people with knee osteoarthritis: systematic review with meta-analysis. Osteoarthr
Cartil. 2013;21:1281–9.
5. De Mattei M, Pasello M, Pellati A, Stabellini G, Massari L, Gemmati D, Caruso
A. Effects of electromagnetic fields on proteoglycan metabolism of bovine
articular cartilage explants. Connect Tissue Res. 2003;44:154–9.
6. Fini M, Torricelli P, Giavaresi G, Aldini NN, Cavani F, Setti S, Nicolini A, Carpi
A, Giardino R. Effect of pulsed electromagnetic field stimulation on knee
cartilage, subchondral and epyphiseal trabecular bone of aged Dunkin
Hartley guinea pigs. Biomed Pharmacother. 2008;62:709–15.
7. Ongaro A, Pellati A, Masieri FF, Caruso A, Setti S, Cadossi R, Biscione R,
Massari L, Fini M, De Mattei M. Chondroprotective effects of pulsed
electromagnetic fields on human cartilage explants. Bioelectromagnetics.
2011;32:543–51.
8. Hilz FM, Ahrens P, Grad S, Stoddart MJ, Dahmani C, Wilken FL, Sauerschnig
M, Niemeyer P, Zwingmann J, Burgkart R, et al. Influence of extremely low
frequency, low energy electromagnetic fields and combined mechanical
stimulation on chondrocytes in 3-D constructs for cartilage tissue
engineering. Bioelectromagnetics. 2014;35:116–28.
9. Graziana A, Ranjeva R, Teissie J. External electric-fields stimulate the electrogenic
calcium sodium exchange in plant-protoplasts. Biochemistry. 1990;29:8313–8.
10. Lee EWC, Maffulli N, Li CK, Chan KM. Pulsed magnetic and electromagnetic
fields in experimental Achilles tendonitis in the rat: A prospective randomized
study. Arch Phys Med Rehabil. 1997;78:399–404.
11. Nelson FR, Zvirbulis R, Pilla AA. Non-invasive electromagnetic field therapy
produces rapid and substantial pain reduction in early knee osteoarthritis: a
randomized double-blind pilot study. Rheumatol Int. 2013;33:2169–73.
12. Mayer-Wagner S, Passberger A, Sievers B, Aigner J, Summer B, Schiergens
TS, Jansson V, Muller PE. Effects of low frequency electromagnetic fields on
the chondrogenic differentiation of human mesenchymal stem cells.
Bioelectromagnetics. 2011;32:283–90.
13. Bassen H, Litovitz T, Penafiel M, Meister R. ELF in vitro eposure systems for
inducing uniform electric and magnetic fields in cell culutre media.
Bioelectromagnetics. 1992;13:183–98.
14. Kraus W, Lechner F. Healing of pseudoarthrosis and spontaneous fractures
with structure-forming electrodynamic potentials. Munch Med Wochenschr.
1972;114:1814–9.
15. Rubin CT, Donahue HJ, Rubin JE, McLeod KJ. Optimization of electric field
parameters for the control of bone remodeling: exploitation of an
indigenous mechanism for the prevention of osteopenia. J Bone Miner Res.
1993;8(Suppl 2):S573–81.
16. Zhai M, Jing D, Tong S, Wu Y, Wang P, Zeng Z, Shen G, Wang X, Xu Q, Luo
E. Pulsed electromagnetic fields promote in vitro osteoblastogenesis
through a Wnt/beta-catenin signaling-associated mechanism.
Bioelectromagnetics. 2016;
17. Heermeier K, Spanner M, Trager J, Gradinger R, Strauss PG, Kraus W, Schmidt
J. Effects of extremely low frequency electromagnetic field (EMF) on
collagen type I mRNA expression and extracellular matrix synthesis of
human osteoblastic cells. Bioelectromagnetics. 1998;19:222–31.
18. Grogan SP, Barbero A, Winkelmann V, Rieser F, Fitzsimmons JS, O'Driscoll S,
Martin I, Mainil-Varlet P. Visual histological grading system for the evaluation
of in vitro-generated neocartilage. Tissue Eng. 2006;12:2141–9.
19. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A,
Speleman F. Accurate normalization of real-time quantitative RT-PCR data by
geometric averaging of multiple internal control genes. Genome Biol. 2002;3
20. Varas L, Ohlsson LB, Honeth G, Olsson A, Bengtsson T, Wiberg C,
Bockermann R, Jarnum S, Richter J. Pennington D, et al: alpha 10 integrin
expression is up-regulated on fibroblast growth factor-2-treated
mesenchymal stem cells with improved chondrogenic differentiation
potential. Stem Cells Dev. 2007;16:965–78.
21. Zhang LM, Su PQ, Xu CX, Yang JL, Yu WH, Huang DS. Chondrogenic
differentiation of human mesenchymal stem cells: a comparison between
micromass and pellet culture systems. Biotechnol Lett. 2010;32:1339–46.
22. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using
real-time quantitative PCR and the 2(T) (−Delta Delta C) method. Methods.
2001;25:402–8.
23. Li S, Yu B, Zhou D, He C, Zhuo Q, Hulme JM. Electromagnetic fields for
treating osteoarthritis. Cochrane Database Syst Rev. 2013;12:CD003523.
24. De Mattei M, Fini M, Setti S, Ongaro A, Gemmati D, Stabellini G, Pellati A,
Caruso A. Proteoglycan synthesis in bovine articular cartilage explants
exposed to different low-frequency low-energy pulsed electromagnetic
fields. Osteoarthr Cartil. 2007;15:163–8.
25. Tan L, Ren Y, van Kooten TG, Grijpma DW, Kuijer R. Low-intensity pulsed
ultrasound (LIPUS) and pulsed electromagnetic field (PEMF) treatments
affect degeneration of cultured articular cartilage explants. Int Orthop. 2015;
39:549–57.
26. Varani K, Padovan M, Vincenzi F, Targa M, Trotta F, Govoni M, Borea PA. A2A
and A3 adenosine receptor expression in rheumatoid arthritis: upregulation,
inverse correlation with disease activity score and suppression of
inflammatory cytokine and metalloproteinase release. Arthritis Res Ther.
2011;13:R197.
27. Ongaro A, Varani K, Masieri FF, Pellati A, Massari L, Cadossi R, Vincenzi F,
Borea PA, Fini M, Caruso A, De Mattei M. Electromagnetic fields (EMFs) and
adenosine receptors modulate prostaglandin E(2) and cytokine release in
human osteoarthritic synovial fibroblasts. J Cell Physiol. 2012;227:2461–9.
28. Vincenzi F, Targa M, Corciulo C, Gessi S, Merighi S, Setti S, Cadossi R, Goldring MB,
Borea PA, Varani K. Pulsed electromagnetic fields increased the anti-inflammatory
effect of A(2)A and A(3) adenosine receptors in human T/C-28a2 chondrocytes
and hFOB 1.19 osteoblasts. PLoS One. 2013;8:e65561.
29. Aaron RK, Boyan BD, Ciombor DM, Schwartz Z, Simon BJ. Stimulation of
growth factor synthesis by electric and electromagnetic fields. Clin Orthop
Relat Res. 2004:30–7.
30. Podda MV, Leone L, Barbati SA, Mastrodonato A, Li Puma DD, Piacentini R, Grassi
C. Extremely low-frequency electromagnetic fields enhance the survival of
newborn neurons in the mouse hippocampus. Eur J Neurosci. 2014;39:893–903.
31. Corallo C, Volpi N, Franci D, Vannoni D, Leoncini R, Landi G, Guarna M,
Montella A, Albanese A, Battisti E, et al. Human osteoarthritic chondrocytes
exposed to extremely low-frequency electromagnetic fields (ELF) and
therapeutic application of musically modulated electromagnetic fields
(TAMMEF) systems: a comparative study. Rheumatol Int. 2013;33:1567–75.
32. Corallo C, Battisti E, Albanese A, Vannoni D, Leoncini R, Landi G, Gagliardi A,
Landi C, Carta S, Nuti R, Giordano N. Proteomics of human primary
osteoarthritic chondrocytes exposed to extremely low-frequency
electromagnetic fields (ELF EMFs) and to therapeutic application of
musically modulated electromagnetic fields (TAMMEF). Electromagn Biol
Med. 2014;33:3–10.
Redeker et al. BMC Complementary and Alternative Medicine  (2017) 17:402 Page 8 of 8
